These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 24043970

  • 21. Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid-enhanced MR Imaging and Dynamic CT.
    Choi SH, Lee SS, Kim SY, Park SH, Park SH, Kim KM, Hong SM, Yu E, Lee MG.
    Radiology; 2017 Mar; 282(3):771-781. PubMed ID: 27797675
    [Abstract] [Full Text] [Related]

  • 22. Gd-EOB-DTPA-enhanced magnetic resonance imaging for bile duct intraductal papillary mucinous neoplasms.
    Ying SH, Teng XD, Wang ZM, Wang QD, Zhao YL, Chen F, Xiao WB.
    World J Gastroenterol; 2015 Jul 07; 21(25):7824-33. PubMed ID: 26167082
    [Abstract] [Full Text] [Related]

  • 23. Differentiating malignant from benign hyperintense nodules on unenhanced T1-weighted images in patients with chronic liver disease: using gadoxetic acid-enhanced and diffusion-weighted MR imaging.
    Moon JY, Kim SH, Choi SY, Hwang JA, Lee JE, Lee J.
    Jpn J Radiol; 2018 Aug 07; 36(8):489-499. PubMed ID: 29876721
    [Abstract] [Full Text] [Related]

  • 24. [Cholangio-hamartoma of the liver (a new case)].
    Maaouni AB, Maaouni A, Tounsi A, Benyahia TD, Abi F, Rifai N.
    Maghrib Tibbi; 1984 Dec 07; 6(4):345-51. PubMed ID: 6100200
    [No Abstract] [Full Text] [Related]

  • 25. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S, Isoda H, Shimizu T, Tamada D, Taura K, Togashi K, Onishi H, Motosugi U.
    Eur Radiol; 2020 Nov 07; 30(11):5992-6002. PubMed ID: 32500195
    [Abstract] [Full Text] [Related]

  • 26. Magnetic resonance findings of bile duct adenoma with calcification.
    Maeda E, Uozumi K, Kato N, Akahane M, Inoh S, Inoue Y, Beck Y, Goto A, Makuuchi M, Ohtomo K.
    Radiat Med; 2006 Jul 07; 24(6):459-62. PubMed ID: 16958429
    [Abstract] [Full Text] [Related]

  • 27. Combining the Arterial Phase of Contrast-Enhanced Ultrasonography, Gadoxetic Acid-Enhanced Magnetic Resonance Imaging and Diffusion-Weighted Imaging in the Diagnosis of Hepatic Nodules ≤20 mm in Patients with Cirrhosis.
    Zhou Y, Jing X, Zhang X, Ding J, Wang Y, Zhou H, Zhang Q, Chen Y, Yue W.
    Ultrasound Med Biol; 2019 Mar 07; 45(3):693-701. PubMed ID: 30606633
    [Abstract] [Full Text] [Related]

  • 28. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE, Kim SH, Lee SJ, Rhim H.
    AJR Am J Roentgenol; 2011 Jun 07; 196(6):W758-65. PubMed ID: 21606265
    [Abstract] [Full Text] [Related]

  • 29. Differentiation between cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: Classification tree analysis applying capsule and septum.
    Min JH, Kim YK, Choi SY, Jeong WK, Lee WJ, Ha SY, Ahn S, Ahn HS.
    Eur J Radiol; 2017 Jul 07; 92():1-10. PubMed ID: 28624005
    [Abstract] [Full Text] [Related]

  • 30. Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma.
    Park MJ, Kim YK, Park HJ, Hwang J, Lee WJ.
    J Comput Assist Tomogr; 2013 Jul 07; 37(6):872-81. PubMed ID: 24270108
    [Abstract] [Full Text] [Related]

  • 31. Intraductal papillary neoplasm of the bile ducts: description of MRI and added value of diffusion-weighted MRI.
    Yoon HJ, Kim YK, Jang KT, Lee KT, Lee JK, Choi DW, Lim JH.
    Abdom Imaging; 2013 Oct 07; 38(5):1082-90. PubMed ID: 23508835
    [Abstract] [Full Text] [Related]

  • 32. High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing "pseudo-washout" on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions.
    Nam SJ, Yu JS, Cho ES, Kim JH, Chung JJ.
    Clin Radiol; 2017 Mar 07; 72(3):247-254. PubMed ID: 27789027
    [Abstract] [Full Text] [Related]

  • 33. MRI of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (≤3 cm) with cirrhosis and chronic viral hepatitis: a comparative study.
    Sheng RF, Zeng MS, Rao SX, Ji Y, Chen LL.
    Clin Imaging; 2014 Mar 07; 38(3):265-72. PubMed ID: 24559750
    [Abstract] [Full Text] [Related]

  • 34. Differentiation of small (≤2 cm) hepatocellular carcinomas from small benign nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images.
    Kwon HJ, Byun JH, Kim JY, Hong GS, Won HJ, Shin YM, Kim PN.
    Abdom Imaging; 2015 Jan 07; 40(1):64-75. PubMed ID: 24997560
    [Abstract] [Full Text] [Related]

  • 35. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY, Kim YK, Lee MW, Park MJ, Hwang J, Lee MH, Lee JW.
    Acta Radiol; 2012 Oct 01; 53(8):830-8. PubMed ID: 22847903
    [Abstract] [Full Text] [Related]

  • 36. Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article.
    Shin SK, Kim YS, Choi SJ, Shim YS, Jung DH, Kwon OS, Choi DJ, Kim JH.
    Medicine (Baltimore); 2017 Jul 01; 96(29):e7278. PubMed ID: 28723741
    [Abstract] [Full Text] [Related]

  • 37. Hepatocellular carcinoma with central scar on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance imaging.
    Han SB, Kim YK, Min JH, Ha SY, Jeong WK, Lee WJ.
    Acta Radiol; 2018 Apr 01; 59(4):393-401. PubMed ID: 28760004
    [Abstract] [Full Text] [Related]

  • 38. Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features.
    Kozaka K, Kobayashi S, Yoneda N, Kitao A, Yoshida K, Inoue D, Ogi T, Koda W, Sato Y, Gabata T, Matsui O.
    Eur Radiol; 2019 Dec 01; 29(12):6489-6498. PubMed ID: 31278576
    [Abstract] [Full Text] [Related]

  • 39. Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver.
    Inchingolo R, De Gaetano AM, Curione D, Ciresa M, Miele L, Pompili M, Vecchio FM, Giuliante F, Bonomo L.
    Eur Radiol; 2015 Apr 01; 25(4):1087-96. PubMed ID: 25430005
    [Abstract] [Full Text] [Related]

  • 40. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-1981.
    N Engl J Med; 1981 Apr 09; 304(15):893-9. PubMed ID: 6259526
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.